Jonathan Bees is a research analyst for HealthLeaders.
A new HealthLeaders Intelligence Report reveals what healthcare executives say are their top difficulties in the use of data analytics.
AI is still in the early stages of development and application, but modest growth is evident, according to a new HealthLeaders Intelligence Report.
Gains from analytics are not only about capturing additional margin. Return on investment for analytics can also be about improving the quality of care, reducing costs, and improving efficiency.
The importance of cultural compatibility is a common theme in any discussion of M&A success or failure, as is establishing a basis for trust between organizations.
Several results from a recent HealthLeaders survey suggest that M&A activity levels may be on the verge of easing.
Health systems and hospitals engaged in M&A activity must remain focused on achieving core financial and clinical objectives.
Despite continued and sometimes unsettling M&A activity in the industry, the fundamental mission of healthcare has not changed.
In a recent HealthLeaders research report, respondents achieved a fairly high level of strength where they have redesigned care delivery with the intent of supporting population health management.
The general trend demonstrates a preference for structures with shared risk in the near term, with a gradual move toward assuming greater downside risk in the longer term.
HealthLeaders' recent research report suggests IT infrastructure accounts for a significant portion of population health investment, because so many areas within it require updating.